Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Interventions
DRUG

Bardoxolone Methyl

Oral, once daily

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY